Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy

Sung Eun Lee, Soo Young Choi, Soo Hyun Kim, Hye Young Song, Hae Lyun Yoo, Mi Young Lee, Hee Jeong Hwang, Ki Hoon Kang, Kyung Mi Kee, Eun Jung Jang, Dong Wook Kim

Division of Hematology
Seoul St. Mary’s Hospital

The Catholic University of Korea
Catholic Univ. of Korea Coll. Med.

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy

Fingerprint

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science